• Something wrong with this record ?

The p53 endoplasmic reticulum stress-response pathway evolved in humans but not in mice via PERK-regulated p53 mRNA structures

L. Fusée, N. Salomao, A. Ponnuswamy, L. Wang, I. López, S. Chen, X. Gu, S. Polyzoidis, S. Vadivel Gnanasundram, R. Fahraeus

. 2023 ; 30 (4) : 1072-1081. [pub] 20230222

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK Free Medical Journals from 2011
PubMed Central from 2011 to 1 year ago
Europe PubMed Central from 2011 to 1 year ago
ProQuest Central from 2000-01-01 to 1 year ago
Open Access Digital Library from 1997-01-01
Health & Medicine (ProQuest) from 2000-01-01 to 1 year ago

Cellular stress conditions activate p53-dependent pathways to counteract the inflicted damage. To achieve the required functional diversity, p53 is subjected to numerous post-translational modifications and the expression of isoforms. Little is yet known how p53 has evolved to respond to different stress pathways. The p53 isoform p53/47 (p47 or ΔNp53) is linked to aging and neural degeneration and is expressed in human cells via an alternative cap-independent translation initiation from the 2nd in-frame AUG at codon 40 (+118) during endoplasmic reticulum (ER) stress. Despite an AUG codon in the same location, the mouse p53 mRNA does not express the corresponding isoform in either human or mouse-derived cells. High-throughput in-cell RNA structure probing shows that p47 expression is attributed to PERK kinase-dependent structural alterations in the human p53 mRNA, independently of eIF2α. These structural changes do not take place in murine p53 mRNA. Surprisingly, PERK response elements required for the p47 expression are located downstream of the 2nd AUG. The data show that the human p53 mRNA has evolved to respond to PERK-mediated regulation of mRNA structures in order to control p47 expression. The findings highlight how p53 mRNA co-evolved with the function of the encoded protein to specify p53-activities under different cellular conditions.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010550
003      
CZ-PrNML
005      
20230801132507.0
007      
ta
008      
230718s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41418-023-01127-y $2 doi
035    __
$a (PubMed)36813920
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Fusée, Leila $u Inserm U1131, 27 Rue Juliette Dodu, 75010, Paris, France
245    14
$a The p53 endoplasmic reticulum stress-response pathway evolved in humans but not in mice via PERK-regulated p53 mRNA structures / $c L. Fusée, N. Salomao, A. Ponnuswamy, L. Wang, I. López, S. Chen, X. Gu, S. Polyzoidis, S. Vadivel Gnanasundram, R. Fahraeus
520    9_
$a Cellular stress conditions activate p53-dependent pathways to counteract the inflicted damage. To achieve the required functional diversity, p53 is subjected to numerous post-translational modifications and the expression of isoforms. Little is yet known how p53 has evolved to respond to different stress pathways. The p53 isoform p53/47 (p47 or ΔNp53) is linked to aging and neural degeneration and is expressed in human cells via an alternative cap-independent translation initiation from the 2nd in-frame AUG at codon 40 (+118) during endoplasmic reticulum (ER) stress. Despite an AUG codon in the same location, the mouse p53 mRNA does not express the corresponding isoform in either human or mouse-derived cells. High-throughput in-cell RNA structure probing shows that p47 expression is attributed to PERK kinase-dependent structural alterations in the human p53 mRNA, independently of eIF2α. These structural changes do not take place in murine p53 mRNA. Surprisingly, PERK response elements required for the p47 expression are located downstream of the 2nd AUG. The data show that the human p53 mRNA has evolved to respond to PERK-mediated regulation of mRNA structures in order to control p47 expression. The findings highlight how p53 mRNA co-evolved with the function of the encoded protein to specify p53-activities under different cellular conditions.
650    _2
$a lidé $7 D006801
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    12
$a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159
650    _2
$a messenger RNA $x genetika $x metabolismus $7 D012333
650    12
$a stres endoplazmatického retikula $x genetika $7 D059865
650    _2
$a kinasa eIF-2 $x genetika $x metabolismus $7 D019892
650    _2
$a posttranslační úpravy proteinů $7 D011499
650    _2
$a protein - isoformy $x metabolismus $7 D020033
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Salomao, Norman $u Inserm U1131, 27 Rue Juliette Dodu, 75010, Paris, France
700    1_
$a Ponnuswamy, Anand $u Inserm U1131, 27 Rue Juliette Dodu, 75010, Paris, France
700    1_
$a Wang, Lixiao $u Department of Medical Biosciences, Umea University, 90185, Umea, Sweden
700    1_
$a López, Ignacio $u Biochemistry-Molecular Biology, Faculty of Science, Universidad de la República, Iguá 4225, 11400, Montevideo, Uruguay $1 https://orcid.org/0000000196698906
700    1_
$a Chen, Sa $u Department of Medical Biosciences, Umea University, 90185, Umea, Sweden
700    1_
$a Gu, Xiaolian $u Department of Medical Biosciences, Umea University, 90185, Umea, Sweden
700    1_
$a Polyzoidis, Stavros $u Department of Neurosurgery, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
700    1_
$a Vadivel Gnanasundram, Sivakumar $u Department of Medical Biosciences, Umea University, 90185, Umea, Sweden. sivakumar.vadivel@umu.se $1 https://orcid.org/0000000191530784
700    1_
$a Fahraeus, Robin $u Inserm U1131, 27 Rue Juliette Dodu, 75010, Paris, France. robin.fahraeus@inserm.fr $u Department of Medical Biosciences, Umea University, 90185, Umea, Sweden. robin.fahraeus@inserm.fr $u RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 65653, Brno, Czech Republic. robin.fahraeus@inserm.fr $1 https://orcid.org/0000000304028492
773    0_
$w MED00005364 $t Cell death and differentiation $x 1476-5403 $g Roč. 30, č. 4 (2023), s. 1072-1081
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36813920 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132503 $b ABA008
999    __
$a ok $b bmc $g 1963149 $s 1196815
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 30 $c 4 $d 1072-1081 $e 20230222 $i 1476-5403 $m Cell death and differentiation $n Cell Death Differ $x MED00005364
LZP    __
$a Pubmed-20230718

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...